Next Generation Protein Therapeutics

Tid 28 September 2010 – 29 September 2010

Plats Sheraton Brussels Hotel Brussels, Belgium

Spotlight Presentation 29th September, 10.15 : Real Time Cell Surface Interaction Analysis Dr. Miriam Dwek , Senior Lecturer in Biochemistry, Department of Molecular & Applied Biosciences, University of Westminster will present drug conjugate data using the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bridging the gap between traditional biosensors and cell based assays. Attana will also be present in the exhibition area, giving conference participants the opportunity to see the Attana Cell 200 instrument firsthand. For 25% delegate discount click here: www.informaglobalevents.com/newsletter/index/id/293258/member// Event homepage: www.informaglobalevents.com/event/nextgen

Kategorier

  • biosensor
  • attana
  • Attana Cell 200 biosensor- Label free, real time kinetics on cells
    Licens:
    Medieanvändning
    Ladda ner
  • Attana Application Note: Glycosylation profile of cancer cells
    Attana Application Note: Glycosylation profile of cancer cells
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Scientific publications pertaining to the Attana systems
    Scientific publications pertaining to the Attana systems
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Early detection of clinical failure
    Attana Application Note: Early detection of clinical failure
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Characterization of complex lectin-cell kinetics
    Attana Application Note: Characterization of complex lectin-cell kinetics
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Crude samples analysis - Screening and characterization of hybridoma supernatants
    Attana Application Note: Crude samples analysis - Screening and characterization of hybridoma supernatants
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Attana Application Note: Crude samples analysis - Direct off-rate screening in supernatants and lysates
    Attana Application Note: Crude samples analysis - Direct off-rate screening in supernatants and lysates
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner

Relaterat innehåll

  • Biosensor- Attana Cell 200, label free, real time kinetics on cells

    Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

  • PEGS 2010 with Attana!

    We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

  • Fight against cancer - Attana's collaborator interviewed

    Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

  • Attana- inspiring health

    At Attana we aim at improving health in society by helping our customers in their scientific research, whether they are university researchers or pharmaceutical companies developing efficient treatment against severe diseases. However, another way to stay healthy is to eat wisely and exercise, and we Attanians exercise in abundance. For instance, several years in a row Attana has...

  • Biotech companies - Ways to work more efficiently

    Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
    Seizing funding opportunities. Companies need to broaden the search for capital to include nontraditional (and non-dilutive) sourc

  • Universities and Innovation

    We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

Relaterade event